Nevirapine concentration in cervicovaginal and oropharyngeal secretions after single-dose administration to the mother

Antiviral Therapy

Volumn 10, Issue 6, 2005, Pages 777-

  Harms, Gundel ^a   Kunz, Andrea ^a   Karcher, Heiko ^a   Mugenyi, Kizito ^b   Kurowski, Michael ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Financial Systems Development Section   (Germany)

^c Vivantes Auguste Viktoria Klinikum   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; NEVIRAPINE;

BODY FLUID; BREAST MILK; DRUG BLOOD LEVEL; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MATERNAL BLOOD; PRIORITY JOURNAL; SINGLE DRUG DOSE; TABLET; VAGINA SECRETION; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; CERVIX UTERI; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; NEVIRAPINE; OROPHARYNX; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REVERSE TRANSCRIPTASE INHIBITORS; VAGINA;

EID: 25444469435     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Gaillard P, Verhofstede C, Mwanyumba F, Claeys P, Cohan V, Mandaliya K, Bwayo J, Plum J & Temmerman M. Exposure to HIV-1 during delivery and mother-to-child transmission. AIDS 2000; 14:2341-2348.
2. Newell, ML. Mechanisms and timing of mother-to-child transmission of HIV-1. AIDS 1998; 12:831-837.
3. Kwieck J, Mwapasa V, Ou CY, Molyneux M, Rogerson S & Meshnick S. Maternal-fetal microtransfusions and HIV-1 mother-to-child transmission. 12th Conference on Retroviruses and Opportunistic Infections. 22-25 February 2005, Boston, MA, USA. Abstract 794.
4. Dooley KC. Tandem mass spectrometry in the clinical chemistry laboratory. Clinical Biochemistry 2003; 36:471-481.
5. Zhang H, Dornadula G, Wu Y, Havlir D, Richman DD & Pomerantz RJ. Kinetic analysis of intravirion reverse transcription in the blood plasma of human immunodeficiency virus type-1 infected individuals: direct assessment of resistance to reverse transcriptase inhibitors in vivo. Journal of Virology 1996; 70:628-634.